Title:Incidentally Discovered Rare Case of Solitary Fibrous Pleural Tumor (SFPT) during Residency Medical Clearance Examination
Volume: 5
Author(s): Mohamed Alhaj Moustafa*, Ahmed Ghanem, Bassam Hammad, Reda, Mohamed H. Badawy, Rajesh Gupta, Eui Young Jeon and Gangaiah Komala Guruvaiah
Affiliation:
- Thoracic and General Surgery Department, Sharjah Kuwait Hospital, Sharjah, UAE
Keywords:
Solitary fibrous pleural tumor, Benign pleural tumor, Pleural tumor, Pleural mass, Embolization of pleural rumor, Rare case.
Abstract:
Background:
A wide variety of tumors affect the pleura, both primary and secondary. The most common are metastatic carcinomas, usually of pulmonary origin.
They manifest as malignant pleural effusion or multifocal pleural lesions. The extrapulmonary source of metastasis is mentioned but occurs less
frequently. Pleural primary tumors other than diffuse malignant mesothelioma are either uncommon or rare and have received less attention. The
World Health Organization (WHO) classified primary tumors of the pleura into three broad histogenetic classes of neoplasms, namely mesothelial
tumors, mesenchymal tumors, and lymphoproliferative disorders.
Case Report:
A 41-year-old male patient was referred to our facility from the prevention medicine department with consolidation in the right lower zone of the
chest, diagnosed as a case of encysted pleural effusion to rule out TB. This was discovered during a routine health examination for residency visa
renewal. After laps and imaging workup, it was diagnosed as Solitary Fibrous Pleural Tumor (SFPT). The first surgical intervention was hampered
by bleeding from the mass itself. Therefore, the patient underwent a second intervention after successful embolization of the arterial supply of the
tumor by the interventional radiologist.
Conclusion:
Primary pleural neoplasms represent a small but significant group of heterogeneous tumors, many of which may mimic each other. Modern
imaging modalities permit diagnosis and play a major role in staging and assessing surgical respectability. Novel molecular and
immunohistochemical markers now allow confirmation of diagnosis and potentially form the basis for future targeted therapies. Embolization of
tumor perfusion has a lifesaving role when needed.
